IMMUNOTOPE, INC.

Address

THE PENNSYLVANIA BIOTECHNOLOGY CENTER
3805 OLD EASTON ROAD
DOYLESTOWN, PA, -

Information

DUNS: 131080983
# of Employees: 9

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. Novel liver fibrosis test for early detection and classification

    Amount: $388,354.00

    DESCRIPTION (provided by applicant): The overall goal of this application is to develop and validate a potential biomarker based assay to determine if it can be used as a noninvasive test to detect th ...

    STTRPhase I2013Department of Health and Human Services
  2. Defining T cell epitopes in Dengue virus infection

    Amount: $2,974,009.00

    DESCRIPTION (provided by applicant): There is a well-recognized need to develop vaccines that stimulates humoral immunity as well as a potent T cell immunity in order to achieve protection from infect ...

    SBIRPhase II2012Department of Health and Human Services
  3. Synthetic Nanoparticle based Universal Influenza Vaccine

    Amount: $598,005.00

    DESCRIPTION (provided by applicant): Influenza viruses are highly infectious RNA viruses that cause epidemic respiratory disease in the human population. There is an urgent unmet need for an influenza ...

    SBIRPhase I2010Department of Health and Human Services
  4. HCC diagnostics defined by fucosylated serum biomarkers

    Amount: $1,082,150.00

    DESCRIPTION (provided by applicant): Our over-all goal has been to develop a diagnostic test for the early detection of liver cancer (hepatocellular carcinoma (HCC)) that is more specific and sensitiv ...

    STTRPhase II2008Department of Health and Human Services
  5. Novel Biomarkers Assessment in the Progression from Androgen Dependent Prostate Cancer to Androgen Independent Prostate Cancer

    Amount: $100,000.00

    Prostate cancer is the most commonly diagnosed form of cancer and the second leading cause of cancer-related death in males. Treatment with androgen ablation therapy after radical prostatectomy (RP) ...

    STTRPhase I2008Army Department of Defense
  6. Defining T cell epitopes in Dengue virus infection

    Amount: $299,998.00

    DESCRIPTION (provided by applicant): Dengue Fever (DF) and Dengue Hemorrhagic Fever (DHF) are significant global public health problems and understanding the overall immune response to infection will ...

    SBIRPhase I2007Department of Health and Human Services
  7. Autoantibodies as serum biomarkers for prostate cancer diagnosis and prognosis

    Amount: $730,000.00

    Prostate cancer is the most commonly diagnosed cancer and second leading cause of cancer-related death in males. A highly sensitive, selective, noninvasive screening assay is needed to diagnose prosta ...

    SBIRPhase II2006Army Department of Defense
  8. HCC diagnostics defined by fucosylated serum biomarkers

    Amount: $216,299.00

    DESCRIPTION (provided by applicant): The overall goal of this proposal is to develop a novel early detection diagnostic for hepatocellular carcinoma based on the detection of glycoproteins that have i ...

    STTRPhase I2006Department of Health and Human Services
  9. Autoantibodies as serum biomarkers for prostate cancer diagnosis and prognosis

    Amount: $120,000.00

    Prostate cancer is the most commonly diagnosed form of cancer and the second leading cause of cancer-related death in males. A highly sensitive, selective, noninvasive screening assay is needed to di ...

    SBIRPhase I2005Army Department of Defense
  10. Identification of auto antigens in ovarian cancer

    Amount: $200,000.00

    DESCRIPTION (provided by applicant): Early diagnosis and immunotherapeutic stimulation of a patient's own immune system to detect and destroy tumors is the best hope for the treatment, prevention a ...

    SBIRPhase I2005Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government